KMDA
Kamada Ltd.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · IL
$7.42
+2.34%Forward multiples
Based on analyst estimates
- P/E forward
- 16.13x
- P/E 2026E
- 15.48x
- P/E 2027E
- 12.81x
- P/E 2028E
- 11.43x
- P/S forward
- 1.94x
Trailing multiples
Trailing twelve months
- P/E TTM
- 19.37x
- PEG TTM
- 0.96x
- Price / book
- 1.59x
- Price / sales
- 2.23x
- Price / cash flow
- 11.89x
Enterprise value
- Enterprise value
- $369.9M
- EV / sales
- 1.93x
- EV / EBITDA
- 8.81x
- EV / EBIT
- 13.29x
- Market cap
- $428.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026